Get tickets

Speakers

Loading
Przemek Obloj

Przemek Obloj

CEO, bit.bio

Przemek is the CEO of bit.bio, a synthetic biology company creating human cells for research, drug discovery, and cell therapy spun out from the University of Cambridge.

Before bit.bio, he spent 20 years as an investor in health, technology and climate at EQT, CVC Capital Partners, and PSP. H led investments into companies including Antelliq, Azelis, CeramTec, Collective Health, Galderma, Recordati, SKY, Snowflake and StarBev, totalling over $5 billion equity. 

Przemek began his career at McKinsey & Company and holds an MBA from INSEAD and an MSc in Finance and Data Science from Warsaw School of Economics.

Sessions